SCHEMBL5341998

SCHEMBL5341998

O=C1COc2cc(Nc3ncc(-c4ccc5c(c4)OCO5)o3)ccc2N1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.47
CYP11B1 P15538 2/20 0.45
CYP11B2 P19099 2/20 0.45
KIF11 P52732 1/20 0.44
GABRG2 P18507 1/20 0.42
GABRB3 P28472 1/20 0.42
GABRA5 P31644 1/20 0.42
TNIK Q9UKE5 1/20 0.42
SYK P43405 2/20 0.41
CLK1 P49759 1/20 0.40
CLK2 P49760 1/20 0.40
DYRK1A Q13627 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
DYRK1B Q9Y463 1/20 0.40
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
NSD2 O96028 2/20 0.40
FYN P06241 1/20 0.40
DYRK2 Q92630 2/20 0.39
PIM1 P11309 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5316958 0.86 VCP (0.52) CYP11B1CYP11B2KIF11GABRG2GABRB3
SCHEMBL5316750 0.86 KIF11 (0.48) CYP11B1CYP11B2KIF11GABRG2GABRB3
SCHEMBL5318196 0.85 KDR (0.52) CYP11B1CYP11B2KIF11GABRG2GABRB3
SCHEMBL5338297 0.83 SYK (0.54) CYP11B1CYP11B2KIF11GABRG2GABRB3
SCHEMBL5334965 0.81 VCP (0.57) CYP11B1CYP11B2KIF11GABRG2GABRB3
SCHEMBL14465950 0.81 KIF11 (0.48) CYP11B1CYP11B2KIF11GABRG2GABRB3
SCHEMBL5319534 0.80 VCP (0.52) SYK
SCHEMBL5339461 0.79 KDR (0.52) SYKROCK1FLT1KDR
SCHEMBL5337884 0.78 SYK (0.48) TNIKSYKCLK1CLK2DYRK1A
SCHEMBL5339243 0.72 SYK (0.56) TNIKSYKCLK2DYRK1ACLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007076161-A2 COMPOUNDS WITH THERAPEUTIC ACTIVITY MYRIAD GENETICS, INC (US) 2007-07-05 WO claimed
WO-2007076161-A2 COMPOUNDS WITH THERAPEUTIC ACTIVITY MYRIAD GENETICS, INC (US) 2007-07-05 WO disclosed
WO-2007076161-A2 COMPOUNDS WITH THERAPEUTIC ACTIVITY MYRIAD GENETICS, INC (US) 2007-07-05 WO disclosed